http://rdf.ncbi.nlm.nih.gov/pubchem/patent/UA-61265-U
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_062eaa8ee443481af236eb740b799aaa |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M23-00 |
| filingDate | 2011-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70ceebfd959c93611123d1bf031a6b20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aab98fae2ed0e64c7b44a0fec9e40db0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a310af108210afe92271868fb443ef2c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_875326a2659e1aa8caefbeb7715d95f1 |
| publicationDate | 2011-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | UA-61265-U |
| titleOfInvention | METHOD OF COMPLEX TREATMENT OF URTELLIUM KIDNEY CANCER |
| abstract | The method of complex treatment of urothelial cancer of the kidney includes nephruretrectomy with resection of the ureteral mouth and subsequent adjuvant polychemotherapy with vinblastine, methotrexate, doxorubicin and cisplatin. Methotrexate and cisplatin are administered endolymphally, and doxorubicin and vinblastine are administered intravenously. Methotrexate and cisplatin are administered endolymphally, and doxorubicin and vinblastine are administered intravenously. |
| priorityDate | 2011-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 21.